Shih, A. H., Meydan, C., Shank, K., Garrett-Bakelman, F. E., Ward, P. S., Intlekofer, A., . . . Levine, R. L. (2017). Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemia. Cancer Discov.
Citação norma ChicagoShih, Alan H., et al. "Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-mutant Acute Myeloid Leukemia." Cancer Discov 2017.
Citação norma MLAShih, Alan H., et al. "Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-mutant Acute Myeloid Leukemia." Cancer Discov 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.